Department of Biotechnology, University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria.
Microb Cell Fact. 2013 Jun 11;12:58. doi: 10.1186/1475-2859-12-58.
In the biopharmaceutical industry, Escherichia coli (E. coli) strains are among the most frequently used bacterial hosts for producing recombinant proteins because they allow a simple process set-up and they are Food and Drug Administration (FDA)-approved for human applications. Widespread use of E. coli in biotechnology has led to the development of many different strains, and selecting an ideal host to produce a specific protein of interest is an important step in developing a production process. E. coli B and K-12 strains are frequently employed in large-scale production processes, and therefore are of particular interest. We previously evaluated the individual cultivation characteristics of E. coli BL21 and the K-12 hosts RV308 and HMS174. To our knowledge, there has not yet been a detailed comparison of the individual performances of these production strains in terms of recombinant protein production and system stability. The present study directly compared the T7-based expression hosts E. coli BL21(DE3), RV308(DE3), and HMS174(DE3), focusing on evaluating the specific attributes of these strains in relation to high-level protein production of the model protein recombinant human superoxide dismutase (SOD). The experimental setup was an exponential carbon-limited fed-batch cultivation with minimal media and single-pulse induction.
The host strain BL21(DE3) produced the highest amounts of specific protein, followed by HMS174(DE3) and RV308(DE3). The expression system HMS174(DE3) exhibited system stability by retaining the expression vector over the entire process time; however, it entirely stopped growing shortly after induction. In contrast, BL21(DE3) and RV308(DE3) encountered plasmid loss but maintained growth. RV308(DE3) exhibited the lowest ppGpp concentration, which is correlated with the metabolic stress level and lowest degradation of soluble protein fraction compared to both other strains.
Overall, this study provides novel data regarding the individual strain properties and production capabilities, which will enable targeted strain selection for producing a specific protein of interest. This information can be used to accelerate future process design and implementation.
在生物制药行业中,大肠杆菌(E. coli)菌株是最常被用于生产重组蛋白的细菌宿主之一,因为它们允许简单的工艺设置,并且已获得美国食品和药物管理局(FDA)批准可用于人体应用。大肠杆菌在生物技术中的广泛应用导致了许多不同菌株的发展,因此选择理想的宿主来生产特定的感兴趣的蛋白质是开发生产工艺的重要步骤。大肠杆菌 B 和 K-12 菌株常用于大规模生产过程,因此特别感兴趣。我们之前评估了大肠杆菌 BL21 和 K-12 宿主 RV308 和 HMS174 的单独培养特性。据我们所知,目前还没有详细比较这些生产菌株在重组蛋白生产和系统稳定性方面的个体表现。本研究直接比较了基于 T7 的表达宿主大肠杆菌 BL21(DE3)、RV308(DE3)和 HMS174(DE3),重点评估了这些菌株在高水平生产模型蛋白重组人超氧化物歧化酶(SOD)方面的特定属性。实验设置为指数碳限制分批补料培养,使用最小培养基和单次脉冲诱导。
宿主菌株 BL21(DE3)产生的特定蛋白量最高,其次是 HMS174(DE3)和 RV308(DE3)。表达系统 HMS174(DE3)通过在整个过程时间内保留表达载体表现出系统稳定性;然而,它在诱导后不久就完全停止生长。相比之下,BL21(DE3)和 RV308(DE3)遇到质粒丢失,但仍保持生长。RV308(DE3)表现出最低的 ppGpp 浓度,这与代谢应激水平相关,与其他两种菌株相比,可溶性蛋白部分的降解最低。
总的来说,这项研究提供了关于个体菌株特性和生产能力的新数据,这将有助于针对特定感兴趣的蛋白质进行有针对性的菌株选择。这些信息可用于加速未来的工艺设计和实施。